Taken together, we observed the LCOR-RUNX1-PLCL1 cascade accounts for multiple anti-tumor activities in ccRCC cells, upholding its candidacy as a novel diagnostic and therapeutic target. Here, PLCL1 is linked to nonpapillary renal cell carcinoma.